Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm<sup>®</sup>- and placebo-controlled trial (BRIDGE) - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm<sup>®</sup>- and placebo-controlled trial (BRIDGE)

DOI Full Paper Access

137

Citations

14

References

2016

Year

Ulrich Mrowietz, Jacek C. Szepietowski, Robert Loewe, Peter van de Kerkhof, Rosa Lamarca, W.G. Ocker, Veronica Tebbs, Ignasi Pau‐Charles

British Journal of Dermatology

Abstract

LAS41008 (DMF) is effective in the treatment of adults with moderate-to-severe chronic plaque psoriasis.

References

	Year	Citations

Page 1